The global bioresorbable medical material market size is expected to reach USD 2,193.01 Million by 2028 at a CAGR of 9.9%, according to the latest report by Reports and Data. Increasing number of orthopedic surgeries performed in geriatric patients, cost-effective surgical procedures, and growing use of biodegradable materials in medical sector are key factors expected to drive market revenue growth over the forecast period. In addition, advancements in orthopedic science and implants are some other factors expected to support market growth going ahead.
Bioresorbable medical materials are absorbed and excreted by the body after they complete their temporary functions of mechanical, scaffolding, and biointegration. New generation of bioresorbable medical devices have been developed over the recent past to minimize the long-term side effects of corrosion-resistant implants. Bioresorbable medical materials or devices are made up of polymers that can be easily degraded over time. This has enabled the medical sector to overcome issues related to non-natural medical devices with regards to biological incompatibility that can lead to toxic side effects and immune rejection. This has increased interest of researchers and pharma companies in bioresorbable medical devices and is expected to continue to be prevalent going ahead.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @https://www.reportsanddata.com/sample-enquiry-form/203
Now that the tide is turning, more worldwide growth in the pharmaceutical business is likely to come from emerging nations, particularly China, where health systems are rapidly developing. Despite the fact that only a few acquisitions were announced or completed, tremendous growth is projected in the future years.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.reportsanddata.com/report-detail/bioresorbable-medical-material-market
Some Key Highlights from the Report:
- Polylactide (PLA) segment is expected to account for largest revenue share in the global market over the forecast period owing to increasing use of PLA in long-term medical implants, high stability of the product, and is non-toxic.
- Orthopedics segment is expected to register considerable revenue growth over the forecast period owing to rising incidence of orthopedic injuries and increasing orthopedic surgical procedures performed across the globe. Bioresorbable materials are widely used to develop orthopedic implants and this is also expected to contribute to revenue growth of the segment over the forecast period.
- North America is expected to register robust revenue CAGR over the forecast period owing to increasing advancement in orthopedic surgical procedures, rising R&D activities, and robust presence of key players in the region.
- Key companies in the market include Evonik, Foster Corporation, Poly-Med Corporation, Zeus Industrial Products, Inc., Ashland, Durect Corporation, Groupe PCAS, DSM, Corbion, and Putnam Plastics.
- In June 2021, Evonik announced the development of a 3D printing PEEK biomaterial, VESTAKEEP Care M40 material, for medical applications with body contact till 30 days. The company believes the material can expand possibilities for personalized care and treatment and expects the material will be suitable for hearing aids, filigree prosthesis, and surgical drilling aids for dentistry.
For the purpose of this report, Reports and Data has segmented the global bioresorbable medical material market on the basis of type, application, and region:
Type Outlook (Revenue, USD Million; Volume in Tons, 2018–2028)
- Polylactic Acid (PLA)
- Polyglycolic Acid (PGA)
- Polysaccharides
- Polycaprolactone (PCL)
- PLGA
Application Outlook (Revenue, USD Million; Volume in Tons, 2018–2028)
- Drug Delivery
- Orthopedics
- Others
Regional Outlook (Revenue, USD Million; Volume in Tons, 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- BENELUX
- Rest of APAC
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- U.A.E.
- Saudi Arabia
- South Africa
- Rest of MEA
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/203
The entry of startups and regional players in the recent years and their increasing focus on drug development and research and advancements in therapeutics and medical devices are also expected to contribute to the growth of the market.
Among the product types, the demand for personalized medicine for cancer is expected to dominate other types over the forecast period attributing to growing demand for customized therapies to treat various types of cancer and growing incidence of cancer globally.
Press Release Available @ https://www.reportsanddata.com/press-release/global-bioresorbable-medical-material-market
Growing advancements in medical therapies to drive market growth
The pharmaceutical and healthcare industry is driven by rapid advancements in customized therapies, medical devices, and surgical procedures. Integration of advanced technologies to accelerate research and development and manufacturing and production activities are some other factors driving market growth.
High prices of certain drugs might affect revenue growth
Launch of high-priced drugs to treat rare and chronic diseases and lesser affordability in middle- and low-income regions might limit their adoption and restrain market growth going ahead. In addition, less knowledge and awareness regarding advanced treatment approaches and lower adoption of advanced technologies might further hamper market growth over the forecast period.
Explore More Industry Research by Reports and Data:
Transplantation Market @ https://www.biospace.com/article/transplantation-market-new-growth-challenges-during-covid-19-industry-type-application-business-opportunities-future-forecast-2030/
Telemedicine Market @ https://www.biospace.com/article/telemedicine-market-revenue-growth-restraints-trends-company-profiles-analysis-and-forecast-till-2030-/
Medical Devices Market @ https://www.biospace.com/article/medical-devices-market-is-expected-to-reach-usd-864-49-billion-in-2030-rising-geriatric-population-biotechnological-advancements/
Leupeptin Market @ https://www.biospace.com/article/leupeptin-market-industry-analysis-competitive-strategies-regional-outlook-and-worldwide-demand-in-2030/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/video